374 related articles for article (PubMed ID: 19154484)
1. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
[TBL] [Abstract][Full Text] [Related]
2. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
Islam S; Jalal S; Wretlind B
Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
[TBL] [Abstract][Full Text] [Related]
3. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.
Poonsuk K; Tribuddharat C; Chuanchuen R
Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230
[TBL] [Abstract][Full Text] [Related]
5. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
Wolter DJ; Black JA; Lister PD; Hanson ND
J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the MexXY multidrug efflux pump and other chromosomal mechanisms on aminoglycoside resistance in Pseudomonas aeruginosa isolates from canine and feline infections.
Poonsuk K; Chuanchuen R
J Vet Med Sci; 2012 Dec; 74(12):1575-82. PubMed ID: 22813987
[TBL] [Abstract][Full Text] [Related]
7. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
Singh M; Yau YCW; Wang S; Waters V; Kumar A
Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
[TBL] [Abstract][Full Text] [Related]
9. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF
Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
[TBL] [Abstract][Full Text] [Related]
11. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
El'Garch F; Jeannot K; Hocquet D; Llanes-Barakat C; Plésiat P
Antimicrob Agents Chemother; 2007 Mar; 51(3):1016-21. PubMed ID: 17194835
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
[TBL] [Abstract][Full Text] [Related]
13. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].
Coban AY; Tanrıverdi Çaycı Y; Yıldırım T; Erturan Z; Durupınar B; Bozdoğan B
Mikrobiyol Bul; 2011 Oct; 45(4):602-8. PubMed ID: 22090290
[TBL] [Abstract][Full Text] [Related]
15. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
Bosso JA; Mauldin PD; Steed LL
Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
[TBL] [Abstract][Full Text] [Related]
17. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
[TBL] [Abstract][Full Text] [Related]
18. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
19. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
[TBL] [Abstract][Full Text] [Related]
20. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
